Try a new search

Format these results:

Searched for:

in-biosketch:true

person:delacm03

Total Results:

86


Cavernous Hemangioma of the Carotid Sheath

Zagzag, Jonathan; Morris, Luc G. T.; Immerman, Sara B.; DeLacure, Mark D.
ISI:000207862500019
ISSN: 0023-852x
CID: 2972142

Cavernous hemangioma of the carotid sheath [Case Report]

Zagzag, Jonathan; Morris, Luc G T; DeLacure, Mark D
PMID: 19328358
ISSN: 0194-5998
CID: 99227

SWALLOWING PHYSIOLOGY AFTER SKULL BASE TUMOR RESECTION [Meeting Abstract]

Lazarus, C; Roland, J; Golfinos, J; DeLacure, M; Amin, M; Lalwani, A
ISI:000272911100063
ISSN: 0179-051x
CID: 107740

TONGUE STRENGTH AND SWALLOWING IN ORAL CANCER PATIENTS [Meeting Abstract]

Prasse, J; Sanfilippo, N; DeLacure, M; Falciglia, D; Branski, R; Ho, M; Ganz, C; Kraus, D; Lee, N; Lazarus, C
ISI:000272911100100
ISSN: 0179-051x
CID: 107741

Conditional survival in head and neck melanoma [Meeting Abstract]

Jethanamest D.; Morris L.G.T.; Delacure M.D.
Objectives: To report changes in survival probabilities as patients survive one or more years with head and neck melanoma, and to characterize prognostic factors for this conditional survival statistic. Study Design: Retrospective population-based cohort study. Methods: All subjects from the Surveillance, Epidemiology and End Results (SEER 17) database of the National Cancer Institute with head and neck cutaneous melanoma were analyzed. Using the life table actuarial method, conditional 5 year disease specific survival (DSS) and relative survival were determined for patients surviving one to ten years after diagnosis. Grouped comparisons were performed for anatomic subsites within the head and neck and the rest of the body. Probabilities were also stratified by histologic subtype, thickness of invasion and lymph node status. Results: Five year DSS for scalp and neck melanomas increases from 83.1% to 93.9% for patients surviving five years, compared to an increase from 89.2% to 96.2% for other anatomic sites. Nodular melanoma displayed the worst initial survival among histologic subtypes (73.4%) but improves to 91% at five years. Conditional DSS for node positive patients improves from 47.9% to 83.1%. Survival at diagnosis is stratified by tumor thickness from 96.7% (T1) to 62.3% (T4), but tends to converge between five to ten years of survivorship. Conclusions: For patients with head and neck melanoma who have survived several years, conditional survival provides accurate and useful prognostic information. In general, expected survival increases with time survived since diagnosis, and for low and high T-stage patients, conditional survival statistics converge over time
EMBASE:2011036436
ISSN: 0023-852x
CID: 122700

CTLA-4, IL17A/B/C/D/E/F, PLZF, CD27, FOXP3, RORgammaT and CD70 expression in mucosal melanoma of head and neck [Meeting Abstract]

Wang, YB; Shibata, R; Zhu, H; Delacure, M; Levis, W; Martiniuk, F
ISI:000268307700074
ISSN: 0945-6317
CID: 102310

Less Is More: VRAM Inset Modification in Glossectomy Reconstruction

Haddock, Nicholas T; Delacure, Mark D; Saadeh, Pierre B
PMID: 18626322
ISSN: 1529-4242
CID: 94600

The basis of racial differences in the incidence of thyroid cancer

Morris, Luc G T; Sikora, Andrew G; Myssiorek, David; DeLacure, Mark D
BACKGROUND: The incidence of thyroid cancer in black Americans is half that in white Americans. It is unknown whether this gap represents a population difference in disease or is attributable to inferior cancer screening in the black population. METHODS: A population-based cohort study of 53,990 patients (1973-2003) was performed using the National Cancer Institute's Surveillance Epidemiology End Results database. Socioeconomic variables were explored using the Healthcare Cost and Utilization Project database and macroeconomic data. RESULTS: Since 1973, thyroid cancer incidence among whites has increased 150.2% (4.0 to 9.9 of 100,000), while incidence among blacks has increased 73.2% (3.0 to 5.1 of 100,000). Across 17 regions, the incidence correlated with the percentage of the population with health insurance (r = 0.56, P = .02). Regression analysis suggested that half of the black-white incidence gap might be attributable to differences in health insurance status. Patients with thyroid cancer were more likely to be insured or reside in wealthier ZIP codes. Black patients were more likely to present at advanced age (RR 1.08, P < .0001) and with tumors >4 cm in size (RR 1.13, P <.0001). Black patients were slightly less likely to present with advanced disease (RR 0.96, P = .0008). Cancer-specific mortality was identical in the two populations. DISCUSSION: Sociodemographic data and differences at presentation support a small detection disparity in thyroid cancer, which may contribute to part of the incidence gap. However, this effect is not sufficiently strong to fully explain the incidence gap. A population difference in the incidence of disease may be coexistent
PMID: 18246401
ISSN: 1534-4681
CID: 76861

Functional reconstruction of glossectomy defects: the vertical rectus abdominus myocutaneous neotongue [Case Report]

Haddock, Nicholas T; DeLacure, Mark D; Saadeh, Pierre B
The vertical rectus abdominus myocutaneous (VRAM) flap is a valuable option for tongue reconstruction. However, the traditional inset (skin to remaining oral mucosa) obviates a more anatomic reconstruction. Eight patients underwent total or subtotal glossectomy with VRAM reconstruction. The muscle inset was supported at the inferior mandibular border attached to the remaining lingual mucosa or gingiva. The neotongue, consisting of skin and subcutaneous fat, was sutured posteriorly to the remaining tongue base, and the other surfaces were trimmed and left unsutured. Reconstruction was successful in all patients. The neotongue assumed palatal configuration, and within 2 weeks uniform granulation tissue followed by mucosalization occurred. One year postoperatively, all patients tolerated ad lib diets, spoke intelligibly, were gastrostomy tube and tracheotomy free and had no evidence of aspiration. This neotongue sits on the mandible under voluntary control, permitting effective obturation against the hard palate and providing successful speech and swallowing
PMID: 18597221
ISSN: 0743-684x
CID: 91434

Oropharyngeal kaposi sarcoma in related persons negative for human immunodeficiency virus

Sikora, Andrew G; Shnayder, Yelizaveta; Yee, Herman; DeLacure, Mark D
OBJECTIVES: Kaposi sarcoma (KS) is a vascular tumor that can affect the mucosa of the upper aerodigestive tract. Although KS is the most common malignancy in patients with acquired immunodeficiency syndrome, it is rare in immunocompetent persons. We describe an unusual presentation of KS in 2 related individuals and describe our attempts to determine whether oropharyngeal KS is associated with human herpesvirus 8 (HHV-8). METHODS: All relevant clinical and surgical information, including information on tumor histopathologic and human immunodeficiency virus (HIV) serologic tests, was abstracted from the patient charts and electronic databases. HHV-8 immunohistochemistry was performed on paraffin-fixed specimens. RESULTS: Both patient 1 and patient 2 (the nephew of patient 1) were referred for workup of a tonsillar mass that was pathologically confirmed to be KS. In each case, HIV serologic testing was negative, and a screening immunologic workup, including a quantitative natural killer cell count, a B- and T-lymphocyte count, and immunoglobulin analysis, also yielded findings that were within normal limits. Immunohistochemistry performed on 1 pathological specimen showed positive staining for the presence of HHV-8, the etiologic agent of KS. CONCLUSIONS: The presence of oropharyngeal KS in 2 related HIV-negative individuals supports a role for genetic factors in susceptibility to KS, a common exposure to an infectious agent such as HHV-8, or both. Whereas most KS cases in industrialized countries are associated with immunodeficiency, clinical and laboratory data do not suggest that either of the patients described in this report are immunodeficient. Their susceptibility to KS may be secondary to a subtle inherited defect in host resistance to HHV-8, or another unknown factor
PMID: 18444476
ISSN: 0003-4894
CID: 79149